Company Description
AplaGen is focussing on design, synthesis, and development of peptides irrespective of medical fields or indications. AplaGen has extensive experience in the fields of lead discovery, lead optimisation, and preclinical development. The main project, the development of an EPO-Mimetic Peptide for veterinary use is running. A further project is the development of a thrombopoietic mimetic peptide for the use in haematology.